zoledronic acid has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell-Baird, C; Costa, L; Demers, L; Harvey, H; Kim, C; Lipton, A | 1 |
| August, KJ; Dalton, A; George, B; Katzenstein, HM; Olson, TA; Rapkin, LB; Wasilewski-Masker, K | 1 |
1 trial(s) available for zoledronic acid and Sarcoma
| Article | Year |
|---|---|
Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imatinib Mesylate; Imidazoles; Kidney Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Piperazines; Prognosis; Prostatic Neoplasms; Pyrimidines; Sarcoma; Survival Rate; Treatment Outcome; Zoledronic Acid | 2010 |
1 other study(ies) available for zoledronic acid and Sarcoma
| Article | Year |
|---|---|
The use of zoledronic acid in pediatric cancer patients.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Child; Child, Preschool; Diphosphonates; Female; Humans; Imidazoles; Infant; Male; Sarcoma; Zoledronic Acid | 2011 |